The action of virginiamycin on nucleic acid and protein synthesis in Bacillus subtilis infected with bacteriophage 2C.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001412:Bacillus subtilis / Q000187:drug effects*; D001426:Bacterial Proteins / Q000096:biosynthesis; D001435:Bacteriophages / Q000187:drug effects*; D004269:DNA, Bacterial / Q000096:biosynthesis; D004279:DNA, Viral / Q000096:biosynthesis; D003864:Depression, Chemical; D004357:Drug Synergism; D005815:Genetic Code; D009696:Nucleic Acids / Q000096:biosynthesis*; D012329:RNA, Bacterial / Q000096:biosynthesis / Q000378:metabolism; D013936:Thymidine / Q000378:metabolism; D014529:Uridine / Q000378:metabolism; D014764:Viral Proteins / Q000096:biosynthesis*; D014779:Virus Replication / Q000187:drug effects
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D004269:DNA, Bacterial; D004279:DNA, Viral; D009696:Nucleic Acids; D012329:RNA, Bacterial; D014764:Viral Proteins; D013936:Thymidine; D014529:Uridine